Product
TBI-223
1 clinical trial
1 indication
Indication
TuberculosisClinical trial
A Phase 2 Randomized, Adaptive, Dose-Ranging, Open-Label Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisStatus: Not yet recruiting, Estimated PCD: 2025-06-10